Diffuse large B-cell lymphoma is an aggressive blood cancer. The standard treatment combines an antibody that targets B cells with four chemotherapy drugs. This cures many patients but fails in about three in ten, and the chemotherapy can harm the heart, a real risk for older people.
Researchers at Tufts Cummings School and UMass Chan re‑analysed blood from a dog clinical trial. Dogs were randomly assigned to three regimens that gave a canine antibody plus a low dose of doxorubicin, then one of three experimental immune‑boosting therapies. Instead of tumour tissue, the team measured gene activity in immune cells in blood at several times, including seven days into treatment.
The study found two genes linked to longer survival and some interferon‑related genes linked to poorer outcome. A simple lab test now detects early warning genes, and researchers will test whether using it can improve treatment choices for dogs and people.
Difficult words
- lymphoma — A serious cancer of a type of white blood cells
- antibody — A protein that targets and binds to cellscanine antibody
- chemotherapy — Strong drugs used to kill cancer cells
- gene — A part of DNA that controls cell traitsgenes
- survival — The length of time a patient lives
- regimen — A planned course of medical treatmentregimens
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think a blood test is better than a tumour tissue test? Why or why not?
- How would you feel about a treatment that can harm the heart?
- Do you agree that tests in dogs can help choose treatments for people? Explain.
Related articles
Tanzania fights rabies with mass dog vaccination
Tanzania is working to stop human rabies by vaccinating dogs, improving surveillance and keeping vaccines cold. High vaccine costs, remote villages and lack of electricity remain challenges, but local and international efforts are growing.
